President and CEO Stephen George Dilly sold $2.6M of Aimmune Therapeutics, Inc.

Sold$2,593,317

$26.24Price

98,846Shares

−15%Stake

What AIMT did after the filing

Prices for AIMT after this filing aren't in yet.

Traded Wed, Oct 4. Filed Fri, Oct 6, 2:02 PM ET, during the session. Not investment advice.